Page last updated: 2024-08-24

aripiprazole and Neoplasms

aripiprazole has been researched along with Neoplasms in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kim, HS; Kim, JY; Lee, BM; Tae, IH; Yoon, S	1
Boettger, S; Breitbart, W	1

Trials

1 trial(s) available for aripiprazole and Neoplasms

Article	Year
An open trial of aripiprazole for the treatment of delirium in hospitalized cancer patients. Palliative & supportive care, 2011, Volume: 9, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Delirium; Female; Humans; Inpatients; Male; Middle Aged; Neoplasms; Piperazines; Prospective Studies; Quinolones; Severity of Illness Index; Statistics, Nonparametric	2011

Other Studies

1 other study(ies) available for aripiprazole and Neoplasms

Article	Year
Low Doses of the Anti-psychotic Drug Aripiprazole Have Strong P-gp-inhibitory Activity and Sensitize Anti-mitotic Drug-resistant Cancer Cells. Anticancer research, 2018, Volume: 38, Issue:9 Topics: Antimitotic Agents; Aripiprazole; ATP Binding Cassette Transporter, Subfamily B; Cell Line, Tumor; Cell Survival; DNA Damage; Down-Regulation; Drug Resistance, Neoplasm; Drug Synergism; Furans; Gene Expression Regulation, Neoplastic; Humans; Ketones; Neoplasms; Vincristine	2018

Article

Year

Low Doses of the Anti-psychotic Drug Aripiprazole Have Strong P-gp-inhibitory Activity and Sensitize Anti-mitotic Drug-resistant Cancer Cells.

Anticancer research, 2018, Volume: 38, Issue:9

Topics: Antimitotic Agents; Aripiprazole; ATP Binding Cassette Transporter, Subfamily B; Cell Line, Tumor; Cell Survival; DNA Damage; Down-Regulation; Drug Resistance, Neoplasm; Drug Synergism; Furans; Gene Expression Regulation, Neoplastic; Humans; Ketones; Neoplasms; Vincristine

2018